Tracy Criswell

Dr. Tracy Criswell

orcid

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
6 January 2017 in Stem Cell Research & Therapy
Verified
Journal Article
Open access
PDF file
JWJames Koudy Williams
James Koudy Williams
ADAshley Dean
Ashley Dean
SLShannon Lankford
Shannon Lankford
TCTracy Criswell
Tracy Criswell
GBGopal Badlani
Gopal Badlani
KAKarl-Erik Andersson
Karl-Erik Andersson
Cell therapy for intrinsic urinary sphincter deficiency (ISD) in women has been moderately effective, and improvements are needed. To improve treatment efficacy, it is important to better understand determinates of cell efficacy in the different patient cohorts. We have reported that in nonhuman primates the chronicity of ISD may affect cell efficacy, but additional factors (age, psychosocial stress, hormone status, body weight) can be associated with many disease/treatment outcomes in women – and these factors are the focus of this study. Adult female cynomolgus monkeys were divided into groups: (1) younger (n = 10, 5–8 years of age) versus older (n = 10, 13–18 years of age); (2) age-matched/socially subordinate (n = 15) versus socially dominant (n = 15); and (3) age-matched lower body weight (n = 6) versus higher body weight (n = 6). Autologous skeletal muscle precursor cells (skMPCs, 5 million) were injected into the urinary sphincter 6 weeks after a surgically induced ISD procedure. Resting and pudendal nerve-stimulated maximal urethral pressures (MUP) were measured before, and 3 and 6 months post-skMPC treatment and urinary sphincter muscle/collagen content within the sphincter complex was measured by quantitative histology 6 months posttreatment. Efficacy of skMPCs on MUP and sphincter muscle/collagen ratios are affected by age (average 40% reduction in efficacy, p < 0.05 vs. younger NHPs), social stress (average 30% reduction in efficacy, p < 0.05 vs. socially dominant) and body weight/fasting glucose concentrations (average 35% reduction in efficacy, p < 0.05 vs. lower body weight). Multiple factors (age, stress-induced dysmenorrhea, and body weight) affect the efficacy of cell therapy to restore structure and function in the urinary sphincter complex in NHPs with ISD. Consideration of, and alternatives for, these patient cohorts should be considered.

19 July 2021 in Bio-Design and Manufacturing
Verified
Journal Article
Closed access
PDF file
DLDiana Lim
Diana Lim
EREric S. Renteria
Eric S. Renteria
DSDrake S. Sime
Drake S. Sime
YJYoung Min Ju
Young Min Ju
JKJi Hyun Kim
Ji Hyun Kim
JYJames Yoo
James Yoo

6 December 2016 in The AAPS Journal
Verified
Journal Article
Closed access
PDF file
YZYu Zhou
Yu Zhou
NSNeel Sharma
Neel Sharma
DDDavid Dukes
David Dukes
MMMaria Myzithras
Maria Myzithras
PGPriyanka Gupta
Priyanka Gupta
TCTracy Criswell
Tracy Criswell

20 April 2021 in Reproductive Sciences
Verified
Journal Article
Closed access
PDF file
SSSivanandane Sittadjody
Sivanandane Sittadjody
TCTracy Criswell
Tracy Criswell
JJJohn D. Jackson
John D. Jackson
Anthony AtalaAnthony Atala
Anthony Atala
JYJames Yoo
James Yoo

26 December 2022 in Stem Cells Translational Medicine
Verified
Journal Article
Open access
PDF file
TCTracy Criswell
Tracy Criswell
CSCorné Swart
Corné Swart
JSJana Stoudemire
Jana Stoudemire
KBKelvin G M Brockbank
Kelvin G M Brockbank
MPMatthew Powell-Palm
Matthew Powell-Palm
MFMichael Floren
Michael Floren
Transporting tissues and organs from the site of donation to the patient in need, while maintaining viability, is a limiting factor in transplantation medicine. One way in which the supply chain of organs for transplantation can be improved is to discover novel approaches and technologies that preserve the health of organs outside of the body. The dominant technologies that are currently in use in the supply chain for biological materials maintain tissue temperatures ranging from a controlled room temperature (+25 °C to +15 °C) to cryogenic (−120 °C to −196 °C) temperatures (reviewed in Criswell et al. Stem Cells Transl Med. 2022). However, there are many cells and tissues, as well as all major organs, that respond less robustly to preservation attempts, particularly when there is a need for transport over long distances that require more time. In this perspective article, we will highlight the current challenges and advances in biopreservation aimed at “freezing biological time,” and discuss the future directions and requirements needed in the field.

5 March 2022 in Stem Cells Translational Medicine
Verified
Journal Article
Open access
PDF file
TCTracy Criswell
Tracy Criswell
CSCorné Swart
Corné Swart
JSJana Stoudemire
Jana Stoudemire
KBKelvin Brockbank
Kelvin Brockbank
MFMichael Floren
Michael Floren
JHJoshua Hunsberger
Joshua Hunsberger
Advances in regenerative medicine manufacturing continue to be a priority for achieving the full commercial potential of important breakthrough therapies. Equally important will be the establishment of distribution chains that support the transport of live cells and engineered tissues and organs resulting from these advanced biomanufacturing processes. The importance of a well-managed distribution chain for products requiring specialized handling procedures was highlighted during the COVID-19 pandemic and serves as a reminder of the critical role of logistics and distribution in the success of breakthrough therapies. This perspective article will provide insight into current practices and future considerations for creating global distribution chains that facilitate the successful deployment of regenerative medicine therapies to the vast number of patients that would benefit from them worldwide.